Published in Diabet Med on November 01, 1990
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet (2001) 3.60
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Diagnosing growth-hormone deficiency in adults. Lancet (1994) 1.73
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
A simple test for autonomic neuropathy in juvenile diabetics. Acta Med Scand (1979) 1.67
Transport of glucose from blood to brain. Physiol Rev (1979) 1.62
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia (1981) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Cimetidine suspension as adjuvant to energy restricted diet in treating obesity. BMJ (1993) 1.44
Cumulative glycaemia as measured by lens fluorometry: association with retinopathy in type 2 diabetes. Diabetologia (2010) 1.41
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia (1994) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
Localised blood-retinal barrier leakage and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1990) 1.39
Monitoring of celiac plexus block in chronic pancreatitis. Pain (1989) 1.37
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34
Accurate superimposition of perimetry data onto fundus photographs. Acta Ophthalmol (Copenh) (1990) 1.29
Increased urinary albumin-excretion rate in benign essential hypertension. Lancet (1974) 1.28
Pathophysiology in diabetic autonomic neuropathy: cardiovascular, hormonal, and metabolic studies. Diabetes (1982) 1.26
Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia (1986) 1.26
Glucagon and plasma catecholamines during beta-receptor blockade in exercising man. J Appl Physiol (1976) 1.25
pH and pancreatic enzymes in the human duodenum during digestion of a standard meal. Scand J Gastroenterol (1966) 1.24
Short stature and diabetic nephropathy. BMJ (1995) 1.24
Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia (1981) 1.24
Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol (1986) 1.23
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab (1995) 1.23
Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1993) 1.23
The influence of stimulus size on perimetric detection of small scotomata. Graefes Arch Clin Exp Ophthalmol (1989) 1.21
Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes (1995) 1.20
The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia (1976) 1.20
Cotton-wool spots and retinal light sensitivity in diabetic retinopathy. Br J Ophthalmol (1991) 1.19
Glomerular structure and function in diabetic nephropathy. Early to advanced stages. Diabetes (1990) 1.18
Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism (1994) 1.13
Renal function in streptozotocin-diabetic rats. Diabetologia (1981) 1.13
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone. Metabolism (1994) 1.12
The pancreatic function following subtotal pancreatectomy for cancer. Scand J Gastroenterol Suppl (1971) 1.12
Potassium transport of the frog retinal pigment epithelium: autoregulation of potassium activity in the subretinal space. J Physiol (1986) 1.11
Changes in renal function during weight loss induced by high vs low-protein low-fat diets in overweight subjects. Int J Obes Relat Metab Disord (1999) 1.10
Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci (2001) 1.10
Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet Med (2000) 1.08
HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens (1986) 1.08
Anaemia in diabetes: Is there a rationale to TREAT? Diabetologia (2006) 1.08
QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes. Scand J Clin Lab Invest (2000) 1.08
Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab (1997) 1.08
Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int Suppl (2000) 1.07
Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia (1984) 1.07
Vitreous fluorophotometry: mathematical analysis of the effect of peripheral leakage on axial scans. Invest Ophthalmol Vis Sci (1989) 1.07
Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy. Diabetes (1981) 1.07
Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ (1995) 1.07
The effect of hypoxia and carbon monoxide exposure on plasma volume and capillary permeability to albumin. Scand J Clin Lab Invest (1972) 1.07
Impaired response of pancreatic polypeptide to hypoglycaemia: an early sign of autonomic neuropathy in diabetics. Br Med J (1979) 1.07
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med (2007) 1.06
Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy. Diabetologia (1989) 1.06
A strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy. Diabetologia (1988) 1.06
Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int (1982) 1.05
Raised serum sialic acid concentration in NIDDM patients with and without diabetic nephropathy. Diabetes Care (1996) 1.05
Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia (1989) 1.05
K+-permeability of the blood-brain barrier, investigated by aid of a K+-sensitive microelectrode. Acta Physiol Scand (1977) 1.04
A combined abnormality in heart rate variation and QT corrected interval is a strong predictor of cardiovascular death in type 1 diabetes. Scand J Clin Lab Invest (2008) 1.04
Incidence of alcoholic chronic pancreatitis in Copenhagen. Scand J Gastroenterol (1982) 1.04
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients. Diabet Med (2001) 1.03
Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh) (1994) 1.03
Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes (1997) 1.03
Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients. Diabetes (1993) 1.02
Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study. Diabetes Care (1997) 1.02
Quantitative vitreous fluorophotometry applying a mathematical model of the eye. Invest Ophthalmol Vis Sci (1985) 1.01
Effects of potassium content in brain-cortex slices from adult rats. Exp Brain Res (1970) 1.01
Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients. Kidney Int (1997) 1.00
Acid glycosaminoglycans in myxoedema. Clin Endocrinol (Oxf) (1982) 1.00
Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone. Horm Metab Res (2005) 1.00
Haemodynamic changes in insulin-induced hypoglycaemia in normal man. Diabetologia (1984) 0.99